These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 31511353)
1. Metabolic Flexibility in Cancer: Targeting the Pyruvate Dehydrogenase Kinase:Pyruvate Dehydrogenase Axis. Woolbright BL; Rajendran G; Harris RA; Taylor JA Mol Cancer Ther; 2019 Oct; 18(10):1673-1681. PubMed ID: 31511353 [TBL] [Abstract][Full Text] [Related]
2. Targeting pyruvate dehydrogenase kinase signaling in the development of effective cancer therapy. Anwar S; Shamsi A; Mohammad T; Islam A; Hassan MI Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188568. PubMed ID: 34023419 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic Targeting of the Pyruvate Dehydrogenase Complex/Pyruvate Dehydrogenase Kinase (PDC/PDK) Axis in Cancer. Stacpoole PW J Natl Cancer Inst; 2017 Nov; 109(11):. PubMed ID: 29059435 [TBL] [Abstract][Full Text] [Related]
4. Metabolic Connection of Inflammatory Pain: Pivotal Role of a Pyruvate Dehydrogenase Kinase-Pyruvate Dehydrogenase-Lactic Acid Axis. Jha MK; Song GJ; Lee MG; Jeoung NH; Go Y; Harris RA; Park DH; Kook H; Lee IK; Suk K J Neurosci; 2015 Oct; 35(42):14353-69. PubMed ID: 26490872 [TBL] [Abstract][Full Text] [Related]
6. Thiamine mimetics sulbutiamine and benfotiamine as a nutraceutical approach to anticancer therapy. Jonus HC; Byrnes CC; Kim J; Valle ML; Bartlett MG; Said HM; Zastre JA Biomed Pharmacother; 2020 Jan; 121():109648. PubMed ID: 31810115 [TBL] [Abstract][Full Text] [Related]
7. Targeting the PDK/PDH axis to reverse metabolic abnormalities by structure-based virtual screening with in vitro and in vivo experiments. Yue J; Xu J; Yin Y; Shu Y; Li Y; Li T; Zou Z; Wang Z; Li F; Zhang M; Liang S; He X; Liu Z; Wang Y Int J Biol Macromol; 2024 Mar; 262(Pt 1):129970. PubMed ID: 38325689 [TBL] [Abstract][Full Text] [Related]
8. Targeting the pyruvate dehydrogenase complex/pyruvate dehydrogenase kinase (PDC/PDK) axis to discover potent PDK inhibitors through structure-based virtual screening and pharmacological evaluation. Gan L; Yang Y; Liang Z; Zhang M; He Y; Zhang SL Eur J Med Chem; 2024 Jan; 264():116008. PubMed ID: 38056298 [TBL] [Abstract][Full Text] [Related]
9. The pyruvate dehydrogenase complex in cancer: An old metabolic gatekeeper regulated by new pathways and pharmacological agents. Saunier E; Benelli C; Bortoli S Int J Cancer; 2016 Feb; 138(4):809-17. PubMed ID: 25868605 [TBL] [Abstract][Full Text] [Related]
10. ROS production induced by BRAF inhibitor treatment rewires metabolic processes affecting cell growth of melanoma cells. Cesi G; Walbrecq G; Zimmer A; Kreis S; Haan C Mol Cancer; 2017 Jun; 16(1):102. PubMed ID: 28595656 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of Pyruvate Dehydrogenase Kinase as a Therapeutic Strategy against Cancer. Sradhanjali S; Reddy MM Curr Top Med Chem; 2018; 18(6):444-453. PubMed ID: 29788890 [TBL] [Abstract][Full Text] [Related]
12. Recent advances in pyruvate dehydrogenase kinase inhibitors: Structures, inhibitory mechanisms and biological activities. Li Y; Xie Z; Lei X; Yang X; Huang S; Yuan W; Deng X; Wang Z; Tang G Bioorg Chem; 2024 Mar; 144():107160. PubMed ID: 38301426 [TBL] [Abstract][Full Text] [Related]
13. Pyruvate dehydrogenase kinases (PDKs): an overview toward clinical applications. Wang X; Shen X; Yan Y; Li H Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33739396 [TBL] [Abstract][Full Text] [Related]
14. Pan-cancer analysis reveals PDK family as potential indicators related to prognosis and immune infiltration. Tao S; Tao K; Cai X Sci Rep; 2024 Mar; 14(1):5665. PubMed ID: 38453992 [TBL] [Abstract][Full Text] [Related]
15. Loss of metabolic flexibility as a result of overexpression of pyruvate dehydrogenase kinases in muscle, liver and the immune system: Therapeutic targets in metabolic diseases. Jeon JH; Thoudam T; Choi EJ; Kim MJ; Harris RA; Lee IK J Diabetes Investig; 2021 Jan; 12(1):21-31. PubMed ID: 32628351 [TBL] [Abstract][Full Text] [Related]
16. Differential inhibition of PDKs by phenylbutyrate and enhancement of pyruvate dehydrogenase complex activity by combination with dichloroacetate. Ferriero R; Iannuzzi C; Manco G; Brunetti-Pierri N J Inherit Metab Dis; 2015 Sep; 38(5):895-904. PubMed ID: 25601413 [TBL] [Abstract][Full Text] [Related]
17. Tissue-specific kinase expression and activity regulate flux through the pyruvate dehydrogenase complex. Klyuyeva A; Tuganova A; Kedishvili N; Popov KM J Biol Chem; 2019 Jan; 294(3):838-851. PubMed ID: 30482839 [TBL] [Abstract][Full Text] [Related]
18. A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence. Kaplon J; Zheng L; Meissl K; Chaneton B; Selivanov VA; Mackay G; van der Burg SH; Verdegaal EM; Cascante M; Shlomi T; Gottlieb E; Peeper DS Nature; 2013 Jun; 498(7452):109-12. PubMed ID: 23685455 [TBL] [Abstract][Full Text] [Related]
19. Nematode pyruvate dehydrogenase kinases: role of the C-terminus in binding to the dihydrolipoyl transacetylase core of the pyruvate dehydrogenase complex. Chen W; Komuniecki PR; Komuniecki R Biochem J; 1999 Apr; 339 ( Pt 1)(Pt 1):103-9. PubMed ID: 10085233 [TBL] [Abstract][Full Text] [Related]
20. Pyruvate dehydrogenase complex stimulation promotes immunometabolic homeostasis and sepsis survival. McCall CE; Zabalawi M; Liu T; Martin A; Long DL; Buechler NL; Arts RJW; Netea M; Yoza BK; Stacpoole PW; Vachharajani V JCI Insight; 2018 Aug; 3(15):. PubMed ID: 30089711 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]